Does LEVOMILNACIPRAN Cause Product use issue? 137 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Product use issue have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 9.9% of all adverse event reports for LEVOMILNACIPRAN.
137
Reports of Product use issue with LEVOMILNACIPRAN
9.9%
of all LEVOMILNACIPRAN reports
130
Deaths
87
Hospitalizations
How Dangerous Is Product use issue From LEVOMILNACIPRAN?
Of the 137 reports, 130 (94.9%) resulted in death, 87 (63.5%) required hospitalization, and 88 (64.2%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 137 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which LEVOMILNACIPRAN Alternatives Have Lower Product use issue Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE